Back To: Home : Featured Technology : Flow Cytometry

CLICK HERE FOR WHAT'S NEW IN:
 

Thermo Fisher Scientific, Expression Pathology to improve identification of cancer-related proteins
January 2010
SHARING OPTIONS:

SAN JOSE, Calif.Thermo Fisher Scientific Inc. also announced in December a collaboration between its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and Expression Pathology Inc., a Rockville, Md.-based tissue proteomic analysis firm.
 
The collaboration will apply Thermo Fisher's expertise in quantitative protein analysis using mass spectrometry and Expression Pathology's patented Director laser microdissection and Liquid Tissue sample processing technologies to accurately measure cancer-related proteins in formalin-fixed paraffin-embedded (FFPE) tissue. The goal of the partnership is to develop a workflow that is more sensitive and provides high-quality, quantitative information about a much wider range of specific proteins that are suspected of being markers for cancer. Financial terms of the collaboration were not released.


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.